Select Equity Group, L.P. Bio Rad Laboratories, Inc. Transaction History
Select Equity Group, L.P.
- $19.9 Billion
- Q1 2025
A detailed history of Select Equity Group, L.P. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Select Equity Group, L.P. holds 265,180 shares of BIO stock, worth $61.1 Million. This represents 0.32% of its overall portfolio holdings.
Number of Shares
265,180
Previous 460,658
42.43%
Holding current value
$61.1 Million
Previous $151 Million
57.32%
% of portfolio
0.32%
Previous 0.69%
Shares
11 transactions
Others Institutions Holding BIO
# of Institutions
462Shares Held
18.9MCall Options Held
12.7KPut Options Held
14.4K-
Vanguard Group Inc Valley Forge, PA1.91MShares$440 Million0.01% of portfolio
-
First Eagle Investment Management, LLC1.57MShares$361 Million0.8% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$357 Million0.01% of portfolio
-
Veritas Asset Management LLP913KShares$210 Million2.52% of portfolio
-
Dimensional Fund Advisors LP Austin, TX877KShares$202 Million0.05% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $5.67B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...